Broach Lifecare IPO listed @ Rs. 47.50

Broach Lifecare IPO GMP grey market premium, review, Subscription, allotment, listing estimate @

👉 Chanakyanipothi.com, a legacy of 31 Years.
India`s Oldest Investment & IPO website.
👉Most Trusted by Investors across India.

Table of Contents

What is the business of Broach Lifecare?

At Maple Hospitals, the company operates a network of boutique hospitals providing comprehensive, round-the-clock care for heart conditions. Its services include non-invasive cardiology procedures such as 2D Echocardiography, Electrocardiography, Treadmill Tests, Holter Monitoring, Ambulatory Blood Pressure Measurement, Stress Tests, and Dobutamine Stress Echocardiography. In June/July 2023, it expanded its offerings to include advanced interventional cardiac services. These now cover coronary angiography, stenting, percutaneous coronary intervention (PCI), and primary PCI for acute myocardial infarction.

It also offers a variety of specialized treatments, including Balloon Mitral-Valvuloplasty, permanent pacemaker implantation, cardiac resynchronization procedures, and Implantable Cardioverter-Defibrillator (AICD) implantation. Its services extend to managing congenital heart conditions such as coarctation of the aorta, stenting, and posterior descending artery closure. Additionally, its comprehensive diagnostic and therapeutic options encompass endovascular revascularization, deep vein thrombosis treatment, and peripheral angioplasty.

Its flagship hospital in Bharuch stands out with its 25 inpatient beds and state-of-the-art diagnostic equipment. This facility is equipped to perform essential tests, including 2D Echocardiography, Electrocardiography, and more, while also offering high-end coronary care. It uses advanced life-saving equipment such as Intra-Aortic Balloon Pumps, Biphasic Defibrillators, Ventilators, BIPAP Machines, Syringe Pumps, Volumetric Infusion Pumps, and Multipara Monitoring Machines. Its capabilities extend to complex procedures involving Cutter Balloons for in-stent blockages, Drug-Eluting Balloons for previously implanted stents, fractional flow reserve assessments, and Rotablator technology for hard, calcified blockages.

The Satellite Hospital in Ankleshwar, a 15-bed facility, serves as a referral center and provides non-surgical, day-to-day care. Strategically located to meet the demand for basic tertiary care, it operates as a self-sustaining unit. Both its main and satellite hospitals hold certifications from the National Accreditation Board for Hospitals & Healthcare Providers (NABH) as a primary-level small healthcare organization. Additionally, it is certified by the Atomic Energy Regulatory Board for our PACS System and hold a Fire Safety Certificate from local regulatory bodies. The company is also a member of Globe Bio Care, ensuring proper biomedical waste disposal.

Get more information about the company @ www.braceport-logistics.com  

Who are the Promoters of Broach Lifecare IPO?

The Promoters of the Company are Dr. Jaykumar Narendra Vyas, Dr. Shachi Jaykumar Vyas and Mrs. Dhyuti Krupesh.

What are the Objects of Broach Lifecare IPO?

The Offer comprises of only fresh issue of shares.

The company proposes to utilize the Net Proceeds from the Issue towards the following objects:

1 Purchase of Machineries;
2 Development of Medical Tourism Web Portal; and
3 General Corporate Purpose

Broach Lifecare IPO GMP grey market premium, review, Subscription, allotment, listing estimate

Broach Lifecare IPO Review

At Maple Hospitals, the company operates a network of boutique hospitals providing comprehensive, round-the-clock care for heart conditions. Its services include non-invasive cardiology procedures such as 2D Echocardiography, Electrocardiography, Treadmill Tests, Holter Monitoring, Ambulatory Blood Pressure Measurement, Stress Tests, and Dobutamine Stress Echocardiography. In June/July 2023, it expanded its offerings to include advanced interventional cardiac services. These now cover coronary angiography, stenting, percutaneous coronary intervention (PCI), and primary PCI for acute myocardial infarction.

Size:  Net size of the IPO is Rs.4.02 crore, comprising of 1608000 shares. Huge oversubscription is not ruled out.
Financial Snapshot: The business is taken over from the proprietorship. The shares are offered at reasonable valuation and offers some listing gains. Market meltdown poses some risk to this IPO
+ from fundamental angle: Apply
+ from grey market angle: ?

Quicklinks

• Staffavailable.com
• BigGaddi.com
• ChanakyaMFGuidance.com
• Magajmari.com
• AnalysisLibrary.com

Broach Lifecare IPO GMP today allotment, review?

Broach Lifecare IPO GMP grey market premium

Broach Lifecare IPO FAQs

What is Broach Lifecare IPO?

This is a SME IPO of 3051200 equity shares of the face value of Rs. 10 aggregating up to Rs.? Crores. The issue is priced at Rs.? per share. The minimum order quantity is ? Shares.

When will Broach Lifecare IPO subscription open?

Broach Lifecare IPO opens on August ?, 2024, and closes on August ?, 2024.

What is the lot size of Broach Lifecare IPO?

Broach Lifecare IPO lot size is ? Shares, and the minimum amount required is Rs.?

How to apply for Broach Lifecare IPO?

You can apply in Broach Lifecare IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.

When is Broach Lifecare IPO allotment?

The finalization of Basis of Allotment for Broach Lifecare IPO will be done on August ?, 2024, and the allotted shares will be credited to your demat account by August ?, 2024.

When is Broach Lifecare IPO listing date?

Broach Lifecare IPO listing date is August ?, 2024.